A new PEPFAR policy implemented June 1 threatens to severely curtail the CDC's global health footprint, raising expert concerns over America's vulnerability to international health crises.
A new Commonwealth Fund report exposes that 1 in 5 privately insured adults face denials for physician-recommended care, leading to delays, worsening health, and debt.
A recent cruise ship hantavirus outbreak highlights critical gaps in treatments and vaccines. Global researchers intensify efforts, battling funding hurdles for this deadly, rare disease.
Breaking NewsA multi-state Listeria outbreak, major Medicaid fraud indictments, and expanding probes into medical school admissions dominate recent health news.
Prescription DrugsExplore Medicare Advantage in 2026: dive into premium trends, out-of-pocket limits, supplemental benefits, and prior authorization policies shaping senior healthcare.
Plan ComparisonsMedicare Advantage enrollment surpasses 55% of eligible beneficiaries in 2026, driving $76 billion in federal spending. Special Needs Plans and market concentration dominate trends.
Breaking NewsDemocrats raise urgent concerns over federal health budget reductions under the Trump administration, citing Ebola and Hantavirus outbreaks, fearing future pandemic vulnerability.
Breaking NewsNew federal guidelines for Title X reorient funding towards fertility and family formation, sparking expert concern over impacts on contraception and maternal mortality in the U.S.
Prescription DrugsExplore expert analysis on the 'One Big Beautiful Bill's' impact on healthcare. Julie Rovner unpacks how this budget legislation could jeopardize health insurance for millions of children nationwide.
Breaking NewsA landmark longitudinal study reveals a stark correlation between high ultraprocessed food intake and increased risk of dementia and cognitive decline in older U.S. adults.
Breaking NewsA new PEPFAR policy implemented June 1 threatens to severely curtail the CDC's global health footprint, raising expert concerns over America's vulnerability to international health crises.
Breaking NewsA new Commonwealth Fund report exposes that 1 in 5 privately insured adults face denials for physician-recommended care, leading to delays, worsening health, and debt.
Breaking NewsA recent cruise ship hantavirus outbreak highlights critical gaps in treatments and vaccines. Global researchers intensify efforts, battling funding hurdles for this deadly, rare disease.
Prescription DrugsThe Supreme Court unanimously sided with Hikma Pharmaceuticals, affirming its right to use 'skinny labels' for generic drugs. This ruling impacts patent law and drug accessibility.
Breaking NewsA recent Ugandan study confirms intravenous artesunate remains the most effective first-line therapy for severe pediatric malaria, even with drug-resistant gene variants, potentially influencing future WHO recommendations.
Breaking NewsThe FDA has approved Zaynich (cefepime-zidebactam) for complicated UTIs, offering a critical new treatment option against escalating multidrug-resistant bacterial threats.
Breaking NewsFederal efforts to dismantle diversity, equity, inclusion, and accessibility (DEIA) programs are showing significant impacts on health equity, workforce diversity, and research.
Breaking NewsA flesh-eating screwworm fly, absent for decades, has been detected in South Texas. USDA confirms the parasite, triggering quarantines and renewed eradication efforts.
Breaking NewsA challenging week in healthcare: incidents of hospital worker assault, extensive Medicare fraud schemes, a massive opioid conviction, and professional misconduct cases surface nationwide.
The Supreme Court unanimously sided with Hikma Pharmaceuticals, affirming its right to use 'skinny labels' for generic drugs. This ruling impacts patent law and drug accessibility.
A recent Ugandan study confirms intravenous artesunate remains the most effective first-line therapy for severe pediatric malaria, even with drug-resistant gene variants, potentially influencing future WHO recommendations.
The FDA has approved Zaynich (cefepime-zidebactam) for complicated UTIs, offering a critical new treatment option against escalating multidrug-resistant bacterial threats.
Federal efforts to dismantle diversity, equity, inclusion, and accessibility (DEIA) programs are showing significant impacts on health equity, workforce diversity, and research.
A flesh-eating screwworm fly, absent for decades, has been detected in South Texas. USDA confirms the parasite, triggering quarantines and renewed eradication efforts.
A challenging week in healthcare: incidents of hospital worker assault, extensive Medicare fraud schemes, a massive opioid conviction, and professional misconduct cases surface nationwide.
Cold Spring Harbor Lab discovers the MYRF-1/LIN-42 protein complex, a non-repeating master clock controlling C. elegans development, offering insights into growth disorders.
A groundbreaking new drug, daraxonrasib, has achieved remarkable success in treating metastatic pancreatic cancer, significantly improving patient survival.
A major study of 8,300 older Brazilians reveals how gender, diet, and lifestyle influence discretionary salt use, impacting cognitive and heart health.
Major health news includes ongoing Ebola outbreaks, US response strategies, controversial ACA fraud allegations, and critical FDA safety warnings on medical devices and drugs.
Groundbreaking research from Baylor and University of Michigan reveals cancer's immune evasion tactic, shutting down MHC I, surprisingly makes it vulnerable to CD4+ T cells, challenging decades of immunology and offering new therapeutic avenues.
Robert F. Kennedy Jr. aims to scrutinize American medical records for autism and vaccine links, coinciding with a CDC website change that has deeply concerned the medical community.
A recent analysis reveals California's Medi-Cal program experienced a dramatic loss of nearly 100,000 undocumented immigrant enrollees in late 2025, linked to Trump-era policies.
The KFF Health News Minute offers concise, original healthcare and policy reporting weekly, providing essential updates for informed decision-making.
Stay informed on Medicare's 2024 changes. Understand premium adjustments, IRMAA thresholds, and essential coverage options for smarter healthcare decisions.
Discover how Medicare's Income-Related Monthly Adjustment Amount (IRMAA) impacts your Part B and D premiums. Understand income tiers and appeal processes.
